ZC3HAV1 Protein

ZC3HAV1 Protein (ZAP)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ZC3HAV1 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">ZF1</td>
<td>Amino acids 51-74</td>
</tr>
<tr>
<td class="label">ZF2</td>
<td>Amino acids 130-153</td>
</tr>
<tr>
<td class="label">ZF3</td>
<td>Amino acids 181-204</td>
</tr>
<tr>
<td class="label">ZF4</td>
<td>Amino acids 233-256</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">ZC3HAV1-L</td>
<td>707</td>
</tr>
<tr>
<td class="label">ZC3HAV1-S</td>
<td>652</td>
</tr>
<tr>
<td class="label">ZC3HAV1-L2</td>
<td>720</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">TRIM25</td>
<td>Ubiquitination</td>
</tr>
<tr>
<td class="label">RNA Exosome</td>
<td>Recruitment</td>
</tr>
<tr>
<td class="label">IRF3/IRF7</td>
<td>Cooperation</td>
</tr>
<tr>
<td class="label">PKR</td>
<td>Cross-talk</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">PABPC1</td>
<td>Antagonism</td>
</tr>
<tr>
<td class="label">MOV10</td>
<td>Cooperation</td>
</tr>
<tr>
<td class="label">Ars2</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Neurons

ZC3HAV1 Protein (ZAP)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ZC3HAV1 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">ZF1</td>
<td>Amino acids 51-74</td>
</tr>
<tr>
<td class="label">ZF2</td>
<td>Amino acids 130-153</td>
</tr>
<tr>
<td class="label">ZF3</td>
<td>Amino acids 181-204</td>
</tr>
<tr>
<td class="label">ZF4</td>
<td>Amino acids 233-256</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">ZC3HAV1-L</td>
<td>707</td>
</tr>
<tr>
<td class="label">ZC3HAV1-S</td>
<td>652</td>
</tr>
<tr>
<td class="label">ZC3HAV1-L2</td>
<td>720</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">TRIM25</td>
<td>Ubiquitination</td>
</tr>
<tr>
<td class="label">RNA Exosome</td>
<td>Recruitment</td>
</tr>
<tr>
<td class="label">IRF3/IRF7</td>
<td>Cooperation</td>
</tr>
<tr>
<td class="label">PKR</td>
<td>Cross-talk</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">PABPC1</td>
<td>Antagonism</td>
</tr>
<tr>
<td class="label">MOV10</td>
<td>Cooperation</td>
</tr>
<tr>
<td class="label">Ars2</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Neurons](/entities/neurons)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Microglia](/entities/microglia)</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Astrocytes](/entities/astrocytes)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Zinc Finger CCCH-Type Antiviral Protein 1 (ZC3HAV1), also known as ZAP, is a host restriction factor that plays a crucial role in the innate antiviral immune response. Originally identified for its ability to inhibit retroviral replication, ZC3HAV1 has emerged as an important player in antiviral defense against various viruses, including those potentially involved in neurodegenerative disease pathogenesis. Its function in targeting viral mRNAs for degradation and modulating immune responses makes it relevant to understanding the viral infection hypotheses in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders. [@zap]

Official Symbol: ZC3HAV1 (ZAP) [@structure] Official Full Name: Zinc Finger CCCH-Type Antiviral Protein 1 [@trim] Molecular Weight: ~82 kDa (isoform 1: 707 amino acids; isoform 2: 652 amino acids) [@zapa] Cellular Location: Cytoplasm (primary), Nucleus (some isoforms) [@zapb] Gene: ZC3HAV1 (Chromosome 7q34) UniProt ID: Q9UHF0

Overview

ZC3HAV1 is expressed in most cell types, including neurons, astrocytes, [microglia](/cell-types/microglia-neuroinflammation), and other cells in the central nervous system. It exists in multiple isoforms with different subcellular localizations and functional properties. The long isoform (ZC3HAV1-L) localizes primarily to the cytoplasm, while a shorter isoform (ZC3HAV1-S) can also localize to the nucleus.

As an antiviral restriction factor, ZC3HAV1:

• Binds specifically to viral mRNAs
• Recruits the RNA exosome for degradation
• Inhibits viral protein translation
• Can also act at earlier stages of the viral life cycle

Protein Structure

ZC3HAV1 contains several distinct structural domains:

CCCH-Type Zinc Finger Domains

The protein contains four CCCH-type zinc finger domains:

These domains recognize specific RNA sequences, particularly CpG-rich elements commonly found in viral genomes.

WWE Domain

Located at amino acids 400-500:

• Mediates protein-protein interactions
• Binds to poly(ADP-ribose) (PAR)
• Involved in signaling complex formation

PARP-Like Domain (PARylation)

Located at amino acids 550-650:

• Contains PARP homology region
• May be catalytically inactive
• Involved in protein interactions

Poly(A)-Nuclease Domain

Located at amino acids 660-707:

• RNase activity in some isoforms
• Contributes to RNA degradation
• Essential for antiviral function

Isoforms

Molecular Function

Antiviral Mechanism

ZC3HAV1 employs multiple mechanisms to inhibit viral replication:

• CCCH fingers bind specific viral RNA sequences
• Prefers CpG-rich sequences (unmethylated)
• Recognizes viral genome elements and mRNAs

• Recruits the RNA exosome complex (EXOSC1-10)
• 3'-5' exonucleolytic degradation
• Prevents translation of viral proteins

• Blocks ribosome loading
• Prevents cap-dependent translation
• Can also affect specific viral proteins

• Some evidence for direct replication interference
• May affect reverse transcription (retroviruses)

RNA Recognition Specificity

ZC3HAV1 preferentially targets:

• RNAs with high CpG content
• Specific sequence motifs (CG-rich elements)
• Viral genomes and transcripts

• Recognition of viral sequence patterns
• Lack of host RNA modifications (e.g., N6-methyladenosine)
• Context-dependent binding

Regulation

ZC3HAV1 activity is tightly regulated:

• TRIM25 E3 ubiquitin ligase ubiquitinates ZC3HAV1
• Enhances its antiviral activity
• Required for optimal function

• Casein kinase 2 (CK2) phosphorylates ZC3HAV1
• Enhances RNA binding
• Increases antiviral activity

• Type I and II interferons induce ZC3HAV1 expression
• Part of ISG response
• Amplifies antiviral state

Pathway Interactions

Innate Immune Signaling

Viral Counter-Defense

Role in Neurodegeneration

Alzheimer's Disease

ZC3HAV1 may play several roles in AD:

• Herpesviruses (HSV-1) implicated in AD
• ZC3HAV1 responds to viral infections
• May modulate [amyloid-beta](/proteins/amyloid-beta) response to infection

• Interferon-stimulated gene
• Contributes to antiviral defense
• May affect chronic inflammation

• Enhancing ZC3HAV1 function
• Antiviral strategies
• Immunomodulation

Parkinson's Disease

In PD, ZC3HAV1 may contribute to:

• Enteroviruses potentially linked to PD
• ZC3HAV1 provides antiviral defense
• Genetic variants may affect susceptibility

• Interferon response in substantia nigra
• Microglial activation
• [Neuroinflammation](/mechanisms/neuroinflammation)

Amyotrophic Lateral Sclerosis

ZC3HAV1 in ALS:

• Potential viral involvement in ALS
• ZC3HAV1 response to infections
• May affect disease progression

• ALS involves RNA processing defects
• ZC3HAV1 in RNA degradation
• May intersect with ALS pathways

Other Neurodegenerative Conditions

• Multiple Sclerosis: Viral triggers and immune response
• Huntington's Disease: RNA metabolism alterations
• Prion Diseases: Viral co-factors explored

Expression in the Brain

Therapeutic Potential

Enhancing Antiviral Defense

• Interferon-based therapies
• Small molecule activators
• Gene therapy approaches

• Enhance ZC3HAV1 activation
• Improve antiviral response

Challenges

• Balancing antiviral immunity with inflammation
• Cell-type specific targeting
• [Blood-brain barrier](/entities/blood-brain-barrier) penetration
• Potential for autoimmunity

Research Directions

Current research areas:

• HSV-1 in AD
• Enteroviruses in PD
• Viral involvement in ALS

• RNA recognition specificity
• Regulation of activity
• Cell-type specific functions

• ZC3HAV1 modulators
• Antiviral strategies
• Immunomodulation

History

Key milestones in ZC3HAV1 research:

• 2002: ZAP identified as HIV-1 restriction factor
• 2005-2010: RNA degradation mechanism elucidated
• 2015-2020: Role in antiviral immunity expanded
• 2020s: Potential links to neurodegeneration explored

Background

The study of Zc3Hav1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• ZC3HAV1 Gene
• TRIM25 Protein
• RNA Exosome Complex
• [Innate Immunity](/mechanisms/neuroinflammation)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
• Type I Interferon Signaling
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Antiviral Immunity

External Links

• [UniProt: ZC3HAV1](https://www.uniprot.org/uniprot/Q9UHF0)
• [NCBI Gene: ZC3HAV1](https://www.ncbi.nlm.nih.gov/gene/9204)
• [Human Protein Atlas: ZC3HAV1](https://www.proteinatlas.org/gene/ZC3HAV1)

References